Published in JAMA on November 22, 2004
Medicine. Moving toward transparency of clinical trials. Science (2008) 4.36
The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication. Dtsch Arztebl Int (2010) 3.36
The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS One (2007) 2.52
Reporting bias in medical research - a narrative review. Trials (2010) 2.44
The Food and Drug Administration's deliberations on antidepressant use in pediatric patients. Pediatrics (2005) 2.37
Potential for conflict of interest in the evaluation of suspected adverse drug reactions: a counterpoint. JAMA (2004) 2.21
Postmarketing surveillance--lack of vigilance, lack of trust. JAMA (2004) 1.78
Research ethics. Rethinking research ethics: the case of postmarketing trials. Science (2012) 1.57
Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenet Genomics (2011) 1.34
Principles for evidence-based drug formulary policy. J Gen Intern Med (2005) 1.22
Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures. Br J Cancer (2005) 1.21
A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class. PLoS One (2012) 1.12
A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel. Clin Pharmacol Ther (2012) 1.00
Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis. BMC Med (2015) 0.99
Natural anti-inflammatory agents for pain relief. Surg Neurol Int (2010) 0.97
Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study. Br J Pharmacol (2006) 0.94
Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules. Epidemiology (2012) 0.91
Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. Pharmacogenet Genomics (2010) 0.85
An event-based approach for comparing the performance of methods for prospective medical product monitoring. Pharmacoepidemiol Drug Saf (2012) 0.83
Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture. Circulation (2010) 0.81
Who has used internal company documents for biomedical and public health research and where did they find them? PLoS One (2014) 0.78
Designing the most favourable study design. Eur J Clin Pharmacol (2005) 0.77
Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so? Proc (Bayl Univ Med Cent) (2008) 0.75
The Potential Return on Public Investment in Detecting Adverse Drug Effects. Med Care (2017) 0.75
Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study. JMIR Public Health Surveill (2015) 0.75
Unwarranted claims of drug efficacy in pharmaceutical sales visits: Are drugs approved on the basis of surrogate outcomes promoted appropriately? Br J Clin Pharmacol (2017) 0.75
An evaluation of the completeness of drug-drug interaction-related information in package inserts. Eur J Clin Pharmacol (2016) 0.75
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med (2006) 6.83
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ (2011) 6.19
Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA (2007) 5.02
Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70
Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology (2013) 4.43
Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol (2005) 4.04
Outcomes of planned home births in Washington State: 1989-1996. Obstet Gynecol (2002) 3.99
Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation (2003) 3.76
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care (2008) 3.65
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ (2009) 3.65
Thiazolidinediones and heart failure: a teleo-analysis. Diabetes Care (2007) 3.62
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ (2008) 3.56
Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst (2010) 3.42
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology (2002) 3.28
Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke (2004) 3.26
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23
Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2008) 3.15
Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14
ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12
Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst (2005) 3.06
Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke (2002) 3.05
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology (2013) 2.98
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92
Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation (2008) 2.85
Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med (2009) 2.83
Risk of HIV-1 in rural Kenya: a comparison of circumcised and uncircumcised men. Epidemiology (2004) 2.82
New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med (2004) 2.80
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77
Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care (2008) 2.76
Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA (2008) 2.76
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol (2007) 2.62
A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis (2004) 2.62
Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology (2013) 2.61
Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 2.55
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (2012) 2.42
Rosiglitazone and cardiovascular risk. N Engl J Med (2007) 2.41
Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med (2007) 2.41
25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2007) 2.40
Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2003) 2.40
COX-2 inhibitors--lessons in drug safety. N Engl J Med (2005) 2.39
Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int (2004) 2.37
Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. Prev Med (2010) 2.36
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Recent trials in hypertension: compelling science or commercial speech? JAMA (2006) 2.30
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes (2011) 2.29
The safety risks of innovation: the FDA's Expedited Drug Development Pathway. JAMA (2012) 2.28
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27
Management guided by brain tissue oxygen monitoring and outcome following severe traumatic brain injury. J Neurosurg (2009) 2.21
Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr (2007) 2.21
Incidence of suicide in persons with cancer. J Clin Oncol (2008) 2.21
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20
Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit Care Med (2004) 2.20
ALLHAT: setting the record straight. Ann Intern Med (2004) 2.19
Dietary phosphorus is associated with greater left ventricular mass. Kidney Int (2013) 2.19
From knowledge to practice in chronic cardiovascular disease: a long and winding road. J Am Coll Cardiol (2004) 2.16
Differences in medical care and disease outcomes among black and white women with heart disease. Circulation (2003) 2.16
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol (2011) 2.06
Ensuring the integrity of clinical practice guidelines: a tool for protecting patients. BMJ (2013) 2.06
The necessity for clinical reasoning in the era of evidence-based medicine. Mayo Clin Proc (2013) 2.06
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med (2008) 2.01
Reporting participation in case-control studies. Epidemiology (2002) 1.99
Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials. Trials (2006) 1.98
A computer case definition for sudden cardiac death. Pharmacoepidemiol Drug Saf (2010) 1.97
Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med (2002) 1.96
Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry (2013) 1.95
Age as a modifiable risk factor for cardiovascular disease. Lancet (2008) 1.94
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening. Med Care (2013) 1.88
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002. JAMA (2004) 1.85
The aprotinin story--is BART the final chapter? N Engl J Med (2008) 1.84
Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension (2006) 1.82
Risk of hip fracture among dialysis and renal transplant recipients. JAMA (2002) 1.81
The prevalence of knee pain and symptomatic knee osteoarthritis among veteran traumatic amputees and nonamputees. Arch Phys Med Rehabil (2005) 1.81
Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 1.78
Incidence of primary urethral carcinoma in the United States. Urology (2006) 1.78
Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol (2011) 1.77
Association between serum uric acid level and chronic liver disease in the United States. Hepatology (2010) 1.76
The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology (2004) 1.74
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol (2009) 1.72
Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial. Pediatr Crit Care Med (2013) 1.70
Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst (2006) 1.70
Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol (2002) 1.70
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA (2004) 1.70
Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc (2002) 1.69
Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev (2005) 1.68
Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68